SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch New ANKASCIN®/MenaQ7 Product: MenaQ7® Metabolic



California, USA – March 14, 2024 – SunWay Biotech and Gnosis by Lesaffre proudly announce their strategic partnership at the Natural Products Expo West. Following the alliance ceremony, the companies unveiled their inaugural product, MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient and aiming at the USD 2 Billion Global vitamin K2 market. This product symbolizes their joint effort and marks the beginning of deeper collaboration in product development and international supply chain integration.

Gnosis, a subsidiary of Lesaffre with 170 years of expertise, focuses on fermentation solutions for nutrition, health, and personal care businesses. A key global player in fermentation for more than a century, Lesaffre, with a €2.7 billion turnover, and established on all continents, counts 11,000 employees.

Julie Lemahieu, Markets and Solutions Director, highlighted Gnosis’s global presence ensures close collaboration with clients worldwide.

MenaQ7® Metabolic combines two key active ingredients, MenaQ7® Vitamin K2 as MK-7 and ANKASCIN® 568-R. MenaQ7® is the only Vitamin K2 as MK-7 clinically proven beneficial for bone and heart health, offering the highest quality assurance. ANKASCIN® 568-R is the world’s only red yeast rice fermentation material without Monacolin K (Statin). SunWay Biotech, invited by the US Pharmacopeial Convention (USP), contributed to the development of a red yeast rice health product chapter, and ANKASCIN® 568-R has obtained New Dietary Ingredient (NDI) status. With over 130 scientific publications, ANKASCIN® 568-R has been recognized for its benefits in addressing various metabolic issues and received the Nutraingredient Asia Awards.

John Pan, General Manager of SunWay, expressed the company’s commitment to enhancing human health through advanced biological transformation processes. Leveraging unique fermentation technology, SunWay maximizes the commercial value of natural functional ingredients. It maintains its industry-leading position through continuous expansion of its strain library and optimization of fermentation core technology. “We are honored to partner with Gnosis by Lesaffre, a key global player in fermentation. Sunway looks forward to supporting quality and unique ingredients to global nutraceuticals.”

As both companies embark on this new chapter of collaboration, SunWay Biotech and Gnosis by Lesaffre aim to expand their business footprint in the US, Asia, and other regions. SunWay Biotech plans to leverage this collaboration to drive more product innovation and promote its superior ingredients to the globe.


About Sunway Biotech:

Founded in 2007, SunWay Biotech Co., Ltd. (Stock Code: 1271) is a leading producer of health food ingredients. With a focus on high-quality red yeast rice and probiotic raw materials, the company has gained global recognition, securing patents in key markets such as the US, Canada, EU, China, Japan, South Korea, and Taiwan. Through innovative integration into health and nutrition products, SunWay Biotech caters to the evolving needs of modern consumers, offering diverse and effective wellness solutions.


About Gnosis by Lesaffre 

Gnosis by Lesaffre harnesses the power of microorganisms and biotransformation processes like fermentation to cultivate nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and well-being. The team draws on its focused research and application capabilities to collaborate with nutraceutical and pharmaceutical brands to develop game-changing products for their customers.

Gnosis by Lesaffre – Exploring Life to Improve Living.


About Lesaffre 

A key global player in fermentation for more than a century, Lesaffre, with a 2.7 billion euro turnover, and established on all continents, counts 11,000 employees and more than 90 nationalities. On the strength of this experience and diversity, we work with customers, partners, and researchers to find ever more relevant answers to the needs of food, health, naturalness, and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms.

To nourish 9 billion people, in a healthy way, in 2050 by making the most of our planet’s resources is a major and unprecedented issue. We believe that fermentation is one of the most promising answers to this challenge.

Lesaffre – Working together to better nourish and protect the planet.


Nutraceutical Business Review: SunWay Biotech and Gnosis by Lesaffre form alliance to launch MenaQ7 Metabolic
BioIT World:SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient
Nutraceutical World: SunWay Biotech, Gnosis by Lesaffre Partner to Launch Vitamin K2, Red Yeast Rice Complex